Etminan Mahyar

Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.

Findings from this large, pharmacoepidemiologic study suggest that 7 or more intravitreous injections of bevacizumab annually is associated with a higher risk of glaucoma surgery and that 4 to 6 injections per year show a…

Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study.

This study found an increased risk of IOPi among nondiabetic patients with ranibizumab and bevacizumab compared with aflibercept. Future studies are needed to validate these findings.

Association of Gabapentin or Pregabalin Use and Incidence of Acute Angle-closure Glaucoma.

To the best of our knowledge this is the first study to investigate the association between gabapentin or pregabalin use and the incidence of AAG.

Risk of glaucoma with bisphosphonate use in patients with osteoporosis: a case-control study.

Patients with osteoporosis who used BPs were at a higher risk for AAC compared to those who did not, and those who were on risedronate were more likely to develop AAC compared to patients who…

In Reply: Controversies on the Use of Glaucoma Medications During Surgery.

Association Between Chronic Oral Nitrate Use and the Risk of Ocular Hypertension and Open-Angle Glaucoma.

The use of oral nitrates was associated with a reduced risk of OAG and POAG over long-term follow-up, while no effect was observed on OHT development.

Increased risk of pigmentary degeneration of the iris and pigmentary glaucoma with fluoroquinolone antibiotics.

The study findings suggest that patients using topical moxifloxacin may have increased risk of developing pigmentary degeneration of the iris and pigmentary glaucoma although the absolute increase was low.

Medications for attention deficit hyperactivity disorder associated with increased risk of developing glaucoma.

Use of amphetamines and atomoxetine had a higher risk for ACG, while use of methylphenidate was associated with a higher risk for OAG.

Risk of angle-closure glaucoma with bupropion and topiramate.

Epidemiologic studies have shown that antidepressants may increase the risk of angle-closure glaucoma. We examined the risk of angle-closure glaucoma with bupropion hydrochloride, a unique, popular antidepressant also marketed as a smoking cessation aid.

Association between glaucoma, glaucoma therapies, and erectile dysfunction.

Our results confirmed an association between ED and glaucoma that cannot be attributed to topical BB use.